STORY
Transforming treatment for sickle cell disease
How can we improve treatment for people with sickle cell disease (SCD)?
In 2025, we took this question to those most affected. Partnering with SCD patient organizations, we asked the patient community about their unmet needs. They highlighted the importance of decreasing pain and fatigue, the need for more efficacious treatments, and a desire for more convenient treatment administration.
Improved ability to return to a productive and social life also rated high.
We integrated these insights into our research, implementing novel endpoints including an eDiary for patients to track pain crises, and patient reported outcome measures to gather data on changes in productivity and activities of daily living.
STORY
Giving a voice to colorectal cancer (CRC) patients
Through patient panel interviews metastatic CRC patients shared their journeys, including their struggles, their needs, and their hopes for more tolerable treatments. Their voices are now shaping our path forward: from co-creating patient-facing materials for pivotal studies to embedding new PRO scales in our trials to measure what truly matters: tolerability.
And we’re not doing this alone. By partnering with patient organizations, we’re expanding patient recruitment, raising awareness of the mechanisms behind two novel investigational therapies, and ensuring the right patients have access to the right information at the right time.
Learn more about our clinical trials
Anise and her mother, Acquired Thrombotic Thrombocytopenia Purpura (aTTP), USA © Chris Kirzeder Photography
“Collaboration on research projects has been very productive and enriching. It’s also worth highlighting the communication with the Sanofi team, which has been clear and efficient. The company has demonstrated a clear commitment to innovation and the development of new solutions.”
“Sanofi is among the top when it comes to trying to understand the patient experience living with a disease and unmet needs, and attempting to incorporate those learnings into their development programs.”